Association of Gene Variants With Incident Myocardial Infarction in the Cardiovascular Health Study
暂无分享,去创建一个
Thomas Lumley | Kenneth Rice | Bruce M Psaty | Russell P Tracy | T. Lumley | B. Psaty | K. Rice | S. Ellis | C. Rowland | M. Malloy | J. Kane | R. Tracy | D. Shiffman | J. Devlin | L. Bare | O. Iakoubova | Judy Z. Louie | May M. Luke | Stephen G Ellis | Ellen S O'Meara | Dov Shiffman | Lance A Bare | Charles M Rowland | Judy Z Louie | Andre R Arellano | Olga Iakoubova | May M Luke | Bradford A Young | Mary J Malloy | John P Kane | James J Devlin | E. O'Meara | A. Arellano | B. Young | Bradford A. Young | B. Psaty
[1] J. Pankow,et al. Five common gene variants identify elevated genetic risk for coronary heart disease , 2007, Genetics in Medicine.
[2] E. Topol,et al. A Polymorphism in the Protease-Like Domain of Apolipoprotein(a) Is Associated With Severe Coronary Artery Disease , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[3] J. Pankow,et al. Prediction of coronary heart disease risk using a genetic risk score: the Atherosclerosis Risk in Communities Study. , 2007, American journal of epidemiology.
[4] M. Sabatine,et al. Asp92Asn Polymorphism in the Myeloid IgA Fc Receptor Is Associated With Myocardial Infarction in Two Disparate Populations: CARE and WOSCOPS , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[5] E. Topol,et al. Gene Variants of VAMP8 and HNRPUL1 Are Associated With Early-Onset Myocardial Infarction , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[6] E. Topol,et al. Identification of four gene variants associated with myocardial infarction. , 2005, American journal of human genetics.
[7] M. Olivier. A haplotype map of the human genome. , 2003, Nature.
[8] M. Olivier. A haplotype map of the human genome , 2003, Nature.
[9] G. Fonarow,et al. Genetic Basis of Atherosclerosis: Part I: New Genes and Pathways , 2004, Circulation.
[10] V. Duffy. Associations between oral sensation, dietary behaviors and risk of cardiovascular disease (CVD) , 2004, Appetite.
[11] Nathaniel Rothman,et al. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. , 2004, Journal of the National Cancer Institute.
[12] P. Raskin,et al. Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.
[13] A. Yashin,et al. Heritability of death from coronary heart disease: a 36‐year follow‐up of 20 966 Swedish twins , 2002, Journal of internal medicine.
[14] G. Reed,et al. Vesicle-associated membrane protein 3 (VAMP-3) and VAMP-8 are present in human platelets and are required for granule secretion. , 2002, Blood.
[15] Mario Cleves,et al. Hardy-Weinberg equilibrium test and allele frequency estimation , 1999 .
[16] L. Kuller,et al. Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study. , 1995, Annals of epidemiology.
[17] L H Kuller,et al. Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study. , 1995, Annals of epidemiology.
[18] M. Cushman,et al. Laboratory methods and quality assurance in the Cardiovascular Health Study. , 1995, Clinical chemistry.
[19] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[20] K. Berg. Lp(a) lipoprotein: an overview. , 1994, Chemistry and physics of lipids.
[21] L. Fried,et al. Recruitment of adults 65 years and older as participants in the Cardiovascular Health Study. , 1993, Annals of epidemiology.
[22] R. Kronmal,et al. The Cardiovascular Health Study: design and rationale. , 1991, Annals of epidemiology.
[23] M. Frick,et al. Lp(a) lipoprotein and pre‐β1‐lipoprotein in patients with coronary heart disease , 1974, Clinical genetics.
[24] C. Furberg,et al. Pre-Beta1-Lipoprotein: Relationship to Angiographically Proven Coronary Heart Disease and to Lp(a) Lipoprotein , 1974 .